Dimitrios Roukos

Prof. Dimitrios Roukos

Centre for Biosystems and Genome Network Medicine, University of Ioannina School of Medicine, Ioannina, Greece
+1

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Cancer Letters
Verified
Journal Article
Closed access
GLGeorgios D. Lianos
Georgios D. Lianos
George A. AlexiouGeorge A. Alexiou
George A. Alexiou
AMAlberto Mangano
Alberto Mangano
AMAlessandro Mangano
Alessandro Mangano
SRStefano Rausei
Stefano Rausei
Dimitrios RoukosDimitrios Roukos
Dimitrios Roukos

1 March 2006 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
CGCarlos A. González
Carlos A. González
PJPaula Jakszyn
Paula Jakszyn
GPGuillem Pera
Guillem Pera
AAAntonio Agudo
Antonio Agudo
SBSheila Bingham
Sheila Bingham
ERElio Riboli
Elio Riboli
Background: Dietary factors are thought to have an important role in gastric and esophageal carcinogenesis, but evidence from cohort studies for such a role is lacking. We examined the risks of gastric cancer and esophageal adenocarcinoma associated with meat consumption within the European Prospective Investigation Into Cancer and Nutrition (EPIC) cohort. Methods: A total of 521 457 men and women aged 35–70 years in 10 European countries participated in the EPIC cohort. Dietary and lifestyle information was collected at recruitment. Cox proportional hazard models were used to examine associations between meat intake and risks of cardia and gastric noncardia cancers and esophageal adenocarcinoma. Data from a calibration substudy were used to correct hazard ratios (HRs) and 95% confidence intervals (CIs) for diet measurement errors. In a nested case–control study, we examined interactions between Helicobacter pylori infection status (i.e., plasma H. pylori antibodies) and meat intakes. All statistical tests were two-sided. Results : During a mean follow-up of 6.5 years, 330 gastric adenocarcinoma and 65 esophageal adenocarcinomas were diagnosed. Gastric noncardia cancer risk was statistically significantly associated with intakes of total meat (calibrated HR per 100-g/day increase = 3.52; 95% CI = 1.96 to 6.34), red meat (calibrated HR per 50-g/day increase = 1.73; 95% CI = 1.03 to 2.88), and processed meat (calibrated HR per 50-g/day increase = 2.45; 95% CI = 1.43 to 4.21). The association between the risk of gastric noncardia cancer and total meat intake was especially large in H. pylori -infected subjects (odds ratio per 100-g/day increase = 5.32; 95% CI = 2.10 to 13.4). Intakes of total, red, or processed meat were not associated with the risk of gastric cardia cancer. A positive but non–statistically significant association was observed between esophageal adenocarcinoma cancer risk and total and processed meat intake in the calibrated model. In this study population, the absolute risk of development of gastric adenocarcinoma within 10 years for a study subject aged 60 years was 0.26% for the lowest quartile of total meat intake and 0.33% for the highest quartile of total meat intake. Conclusion: Total, red, and processed meat intakes were associated with an increased risk of gastric noncardia cancer, especially in H. pylori antibody-positive subjects, but not with cardia gastric cancer.

28 February 2006 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
CGCarlos A. González
Carlos A. González
GPGuillem Pera
Guillem Pera
AAAntonio Agudo
Antonio Agudo
HBH. Bas Bueno‐De‐Mesquita
H. Bas Bueno‐De‐Mesquita
MCMarco Ceroti
Marco Ceroti
ERElio Riboli
Elio Riboli
It is considered that fruit and vegetable (F&V) protect against oesophagus and gastric cancer (GC). However, 2 recent meta‐analyses suggest that the strength of association on GC seems to be weaker for vegetables than for fruit and weaker in cohort than in case‐control studies. No evidence exists from cohort studies about adenocarcinoma of oesophagus (ACO). In 521,457 men and women participating in the EPIC cohort in 10 European countries, information of diet and lifestyle was collected at baseline. After an average of 6.5 years of follow‐up, a total of 330 GC and 65 ACO, confirmed and classified by a panel of pathologists, was used for the analysis. We examined the relation between F&V intake and GC and ACO. A calibration study in a sub‐sample was used to control diet measurement errors. In a sub‐sample of cases and a random sample of controls, antibodies against Helicobacter pylori (Hp) were measured and interactions with F&V were examined in a nested case‐control study. We observed no association with total vegetable intake or specific groups of vegetables and GC risk, except for the intestinal type, where a negative association is possible regarding total vegetable (calibrated HR 0.66; 95% CI 0.35–1.22 per 100 g increase) and onion and garlic intake (calibrated HR 0.70; 95% CI 0.38–1.29 per 10 g increase). No evidence of association between fresh fruit intake and GC risk was observed. We found a negative but non significant association between citrus fruit intake and the cardia site (calibrated HR 0.77; 95% CI 0.47–1.22 per 100 g increase) while no association was observed with the non‐cardia site. Regarding ACO, we found a non significant negative association for vegetable intake and for citrus intake (calibrated HRs 0.72; 95% CI 0.32–1.64 and 0.77; 95% CI 0.46–1.28 per 100 and 50 g increase, respectively). It seems that Hp infection does not modify the effect of F&V intake. Our study supports a possible protective role of vegetable intake in the intestinal type of GC and the ACO. Citrus fruit consumption may have a role in the protection against cardia GC and ACO.

1 August 2000 in Cancer Treatment Reviews
Verified
Journal Article
Closed access
PDF file
Dimitrios RoukosDimitrios Roukos
Dimitrios Roukos

1 April 2004 in Cancer Treatment Reviews
Verified
Journal Article
Closed access
EPEvangelos Paraskevaidis
Evangelos Paraskevaidis
MAMarc Arbyn
Marc Arbyn
ASAlexandros Sotiriadis
Alexandros Sotiriadis
EDEmmanuel Diakomanolis
Emmanuel Diakomanolis
PMPierre Martin-Hirsch
Pierre Martin-Hirsch
Dimitrios RoukosDimitrios Roukos
Dimitrios Roukos

1 March 2007 in Cancer Biology & Therapy
Verified
Journal Article
Closed access
Dimitrios RoukosDimitrios Roukos
Dimitrios Roukos
SMSamuel Murray
Samuel Murray
EBEvangelos Briasoulis
Evangelos Briasoulis
The continuous flow of molecular genetic information has cautiously started integrating into clinical practice changing the future landscape of the clinical management of cancer. Germline mutation ...